SBI Securities’s Eikon Therapeutics EIKN Stock Holding History
Bought
Maintained
Sold
Other funds holding EIKN
PFSRSONJ
IA
AP
FFO
SBI Securities's EIKN Position: Q2 2026 in Review
SBI Securities opened a new position in Eikon Therapeutics (EIKN) in Q2 2026: 2 shares worth $26. The stake represents ﹤0.01% of the portfolio and ranks #3800 among its holdings.
5 funds tracked by Wall St. Rank hold EIKN as of Q2 2026.
- SBI Securities held 2 shares of Eikon Therapeutics worth $26 as of Q2 2026.
- Eikon Therapeutics was a new SBI Securities position in Q2 2026.
- Eikon Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3800 holding.
- 5 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q2 2026.
Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.